# 1st Gen Model Walgreens Boots Alliance, Inc. Drug stores & proprietary stores
- $77.26Last close price
at 27-jun-2017 -
Subscribe >>
Deal exit on
June 28, 2017 Deal entry on
June 28, 2017 - 2.23%Expected margin
- 58.33% successful of 24 deals
WBA
Model's trade recommendations 0.88% Return for period
-0.60% Annual return
$83.81B Market Cap
β 1.20
WBA
Model (following trade recommendations)WBA
Underlying stockS&P 500
Index- 1.50 (1.93%) Div (Yield)
- STRONG BUY Analysts consensus recommendation
Walgreens Boots Alliance, Inc. operates as a retail drugstore chain. The Company sells prescription and non-prescription drugs, as well as general merchandise products, including household items, convenience and fresh foods, personal care, beauty care, photofinishing and candy. Its pharmacy, health and wellness services include retail, specialty, infusion and respiratory services, mail service and convenient care clinics. The Company offers its products and services through drugstores, as well as through mail, by telephone and online. Walgreens Boots Alliance, Inc., is based in Deerfield, Illinois.
Industry sector: Retail/Wholesale
Sector classification: Drug stores & proprietary stores
Deep Learning based analysis and prediction model for Walgreens Boots Alliance, Inc. (WBA) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Oct. 22, 2015.
Market data for WBA model training are being downloaded from the Quandl premium datasets on a daily basis.
Model is being retrained on a daily basis.
| Float | 935M |
| P/E | 16.46 |
| Shares Outstanding | 1081M |
| % Held by Insiders | 13.50% |
| % Held by Institutions | 60.63% |
| EPS (last reported FY) | $4.59 |
| EPS (last reported Q) | $1.36 |
| EPS, estimated (last reported Q) | $1.36 |
| Total revenues | $117 B |
| Net income | $4 B |